Kishan J. Pandya, M.D.

See information for Patients. Viewing information for Researchers.

Current Appointments

• Professor Emeritus - Department of Medicine (SMD)

Education
MBBS Medicine	India-Baroda Univ Med Coll	1972

Post-Doctoral Training & Residency
VA Hospital Fellow, Hematology University of Wisconsin Program Madison, Wisconsin	1978 - 1979
Wisconsin Clinical Cancer Center Fellow, Medical Oncology University of Wisconsin Hospitals Madison, Wisconsin	1976 - 1978
Yale University School of Medicine at Norwalk Hospital, Norwalk, Connecticut, Intern/ Resident, Internal Medicine	1973 - 1976

Recent Journal Articles
Showing the 5 most recent journal articles. (48 available)
Pandya KJ; Hu P; Osborne CK; Falkson G; Tormey DC; . "Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185)." American journal of clinical oncology. 2007; 30(2):113-25.
Pandya KJ; Dahlberg S; Hidalgo M; Cohen RB; Lee MW; Schiller JH; Johnson DH; . "A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500)." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2007; 2(11):1036-41.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ. "Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial." Lancet. 2005; 366(9488):818-24.
Pandya KJ; Thummala AR; Griggs JJ; Rosenblatt JD; Sahasrabudhe DM; Guttuso TJ; Morrow GR; Roscoe JA. "Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer." Breast cancer research and treatment. 2004; 83(1):87-9.
Pandya KJ; Lefkopoulou M; Petrelli NJ; Vaughn DJ; Smith TJ; Harris JE; Haller DG; . "Phase II study of cisplatin and 5-fluorouracil (PF) and mitomycin C, vincristine, cisplatin and 5-fluorouracil (MVPF) in patients with metastatic large bowel cancer: an Eastern Cooperative Oncology Group study (EST 1285)." Oncology. 2004; 66(2):118-25.